Vanguard Group’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$847M Sell
13,272,165
-1,065,046
-7% -$65.6M 0.01% 787
2025
Q3
$904M Sell
14,337,211
-322,380
-2% -$22.5M 0.01% 753
2025
Q2
$1.09B Buy
14,659,591
+79,988
+0.5% +$6.29M 0.02% 647
2025
Q1
$1.28B Sell
14,579,603
-222,471
-2% -$21M 0.02% 569
2024
Q4
$1.35B Sell
14,802,074
-7,866
-0.1% -$807K 0.02% 571
2024
Q3
$1.66B Sell
14,809,940
-13,562
-0.1% -$1.36M 0.03% 525
2024
Q2
$1.45B Buy
14,823,502
+13,097
+0.1% +$1.3M 0.03% 526
2024
Q1
$1.48B Sell
14,810,405
-29,318
-0.2% -$2.58M 0.03% 535
2023
Q4
$1.33B Buy
14,839,723
+61,580
+0.4% +$4.91M 0.03% 546
2023
Q3
$1.13B Sell
14,778,143
-231,643
-2% -$19.2M 0.03% 553
2023
Q2
$1.26B Sell
15,009,786
-51,306
-0.3% -$4.17M 0.03% 534
2023
Q1
$1.27B Buy
15,061,092
+66,843
+0.4% +$5.74M 0.03% 521
2022
Q4
$1.22B Sell
14,994,249
-181,684
-1% -$14.6M 0.03% 516
2022
Q3
$1.08B Sell
15,175,933
-673,109
-4% -$60.5M 0.03% 531
2022
Q2
$1.42B Sell
15,849,042
-159,485
-1% -$16.5M 0.04% 471
2022
Q1
$1.79B Sell
16,008,527
-18,335
-0.1% -$2.15M 0.04% 460
2021
Q4
$1.94B Sell
16,026,862
-94,782
-0.6% -$10.5M 0.04% 449
2021
Q3
$1.62B Buy
16,121,644
+80,157
+0.5% +$8.84M 0.04% 479
2021
Q2
$1.87B Buy
16,041,487
+238,735
+2% +$28.7M 0.05% 444
2021
Q1
$1.74B Buy
15,802,752
+1,028,658
+7% +$112M 0.05% 439
2020
Q4
$1.48B Sell
14,774,094
-201,311
-1% -$18.7M 0.04% 456
2020
Q3
$1.17B Sell
14,975,405
-549,027
-4% -$41.4M 0.04% 476
2020
Q2
$1.08B Buy
15,524,432
+531,777
+4% +$33.5M 0.04% 473
2020
Q1
$698M Buy
14,992,655
+360,722
+2% +$23.2M 0.03% 542
2019
Q4
$1.16B Buy
14,631,933
+23,889
+0.2% +$1.84M 0.04% 498
2019
Q3
$1.08B Sell
14,608,044
-221,438
-1% -$15.9M 0.04% 494
2019
Q2
$1.15B Buy
14,829,482
+49,886
+0.3% +$3.79M 0.04% 473
2019
Q1
$1.12B Buy
14,779,596
+428,209
+3% +$34M 0.04% 465
2018
Q4
$1.05B Buy
14,351,387
+122,338
+0.9% +$9.75M 0.05% 447
2018
Q3
$1.36B Buy
14,229,049
+2,131
+0% +$211K 0.05% 411
2018
Q2
$1.42B Buy
14,226,918
+188,068
+1% +$19.9M 0.06% 380
2018
Q1
$1.48B Buy
14,038,850
+173,039
+1% +$17.5M 0.06% 350
2017
Q4
$1.28B Sell
13,865,811
-147,445
-1% -$13.4M 0.06% 402
2017
Q3
$1.27B Buy
14,013,256
+15,075
+0.1% +$1.28M 0.06% 379
2017
Q2
$1.18B Sell
13,998,181
-89,682
-0.6% -$7.23M 0.06% 387
2017
Q1
$1.14B Buy
14,087,863
+557,858
+4% +$43.9M 0.06% 382
2016
Q4
$1.02B Buy
13,530,005
+699,764
+5% +$50.5M 0.06% 391
2016
Q3
$868M Sell
12,830,241
-58,826
-0.5% -$3.95M 0.05% 438
2016
Q2
$875M Buy
12,889,067
+374,294
+3% +$27.5M 0.05% 409
2016
Q1
$904M Buy
12,514,773
+326,689
+3% +$21.4M 0.06% 384
2015
Q4
$823M Buy
12,188,084
+173,987
+1% +$12.2M 0.06% 392
2015
Q3
$778M Buy
12,014,097
+618,859
+5% +$45.7M 0.06% 393
2015
Q2
$932M Buy
11,395,238
+268,274
+2% +$20.7M 0.06% 348
2015
Q1
$771M Buy
11,126,964
+113,731
+1% +$8.21M 0.05% 415
2014
Q4
$835M Buy
11,013,233
+326,899
+3% +$25.8M 0.06% 359
2014
Q3
$864M Buy
10,686,334
+165,735
+2% +$13.8M 0.07% 315
2014
Q2
$919M Buy
10,520,599
+142,178
+1% +$12.4M 0.07% 299
2014
Q1
$895M Sell
10,378,421
-404,879
-4% -$33.2M 0.08% 290
2013
Q4
$870M Buy
10,783,300
+307,700
+3% +$23.9M 0.08% 274
2013
Q3
$816M Sell
10,475,600
-29,421
-0.3% -$2.27M 0.08% 271
2013
Q2
$735M Buy
+10,505,021
New +$732M 0.08% 280

Other funds holding EMN

Vanguard Group's EMN Position: Q4 2025 in Review

Vanguard Group reduced its Eastman Chemical (EMN) stake by 7.4% in Q4 2025, selling an estimated $65.6M and leaving 13,272,165 shares worth $847M. The position accounts for 0.01% of the portfolio, ranked #787.

Vanguard Group first reported a position in EMN in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.94B in Q4 2021. 630 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

  • Vanguard Group held 13,272,165 shares of Eastman Chemical worth $847M as of Q4 2025.
  • Vanguard Group sold 1,065,046 Eastman Chemical shares in Q4 2025, an estimated $65.6M.
  • Eastman Chemical made up 0.01% of Vanguard Group's portfolio in Q4 2025, its #787 holding.
  • Vanguard Group first reported a position in Eastman Chemical in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's Eastman Chemical position peaked at $1.94B in Q4 2021.
  • 630 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.